×

RNS Number : 7491Z

Chesterfield Resources PLC

05 September 2018

 

5 September 2018

 

CHESTERFIELD RESOURCES PLC

("Chesterfield" or the "Company") (TIDM: CHF)

 

Chesterfield mobilises drill to commence programme

Operational and corporate update

 

Chesterfield Resources plc is pleased to announce the signing of a diamond drilling contract with GEOPS Bolkan. The drilling program is to include a minimum of 4,000 metres of diamond drilling on the Company's Troodos West properties in the Republic of Cyprus to explore primarily for copper and gold.  

 

Highlights 

·    Diamond drill contract awarded to GEOPS Bolkan of Bulgaria

·    Mobilisation initiated, with drilling expected to start by the end of September

·  Cyprus Mines Service, Department of Forests, Water Development Department and local communities supportive of work programme

·     Drilling to start at the Evloimeni prospect, at Troodos West, before moving to adjacent targets

·   Review of historic data at Evloimeni highlights the existence of Cyprus-type volcanic sulphide copper-gold-zinc-silver mineralization

·     New interpretation of airborne and ground geophysical data underway

·     An office is being established in Cyprus, and a local geological team recruited

 

Martin French, Executive Chairman said: "We are very pleased to be commencing our drill programme in Cyprus, following our recent £2 million financing. The seven contiguous targets at Troodos West are highly prospective with evidence of mineralisation at surface, numerous historic mines, workings, drill holes and geophysical surveys. Permitting is proceeding at our Troodos North and Troodos East projects, which will add a considerable number of new brownfield targets to our drilling campaign."

 

Operational update

 

Chesterfield's initial focus is to advance the Troodos West exploration project (map available here: https://www.chesterfieldresourcesplc.com/#news) where a number of high-priority prospects have already been identified.

 

Chesterfield has chosen the Evloimeni prospect within its 100% owned Troodos West project as its first drill target. Evloimeni is a mineralised system with a number of historic drill results. There is evidence of earth works on the site, before the area was abandoned following the Turkish invasion of Cyprus in 1974.

 

Drilling (unverified archival data) by the Cyprus Sulphur and Copper Corporation in the 1950s highlighted:

 

CD-E1: sulphide mineralisation from 4.6 m (beneath "surface wash") to end-of-hole at 76.2 m including:

16.8 m @ 0.69 g/t Au, 3.74 g/t Ag, 0.94% Cu, 1.04% Zn from 4.6 m

        incl. 9.1 m @ 0.8 g/t Au, 3.62 g/t Ag, 1.27% Cu, 1.34% Zn from 10.7 m

 

CD-E15: 44.2 m; sulphide mineralisation from surface (beneath a thin "oxidised capping") to end-of-hole, but strongest from 1.5 – 22.9 m including:

30.5 m @ 0.55% Cu, 2.2% Zn from 1.5 m

                incl. 21.3 m @ 0.72% Cu, 2.93% Zn from 1.5 m

                incl. 10.7 m @ 0.89% Cu, 4.56% Zn from 1.5 m

 

Publically reported drilling in 2011 highlighted:

 

11EV01:

42.0 m @ 0.66 g/t Au, 1.86 g/t Ag, 0.11% Cu, 0.11% Zn from 8.4 m,

                incl. 24.3 m @ 1.0 g/t Au, 2.74 g/t Ag, 0.11% Cu, 0.11% Zn from 8.4 m

 

The Evloimeni prospect is located only 1,100 m from the large Limni deposit where 8,110,000 tonnes at 1.1 % copper was reportedly exploited.

 

Evloimeni is interpreted by Chesterfield to be a large Cu-Au-Zn system. Drilling will comprise an initial 7-hole fence across 250 m of the mineralization to help define the distribution of Cu-Au-Zn grades and the textures and alteration associated with mineralization. This initial fence of holes will comprise approximately 1,000 m of drilling.

 

Ongoing field work is being integrated with a review of historic data across the Troodos West Project. A number of historic geophysical surveys have been completed at Troodos West, including helicopter VTEM, IP and gravity surveys. The Company is currently reviewing this data to assist with further targeting.

 

Chesterfield is now in the process of opening an office in Cyprus and recruiting a team of geologists locally. The team will be led by Dr Michael Green, the Country Manager for Chesterfield.

 

Corporate update

 

Chesterfield has established a new head office in London and has changed its registered address to 7-9 Swallow Street, London W1B 4DE, UK with effect from 4 September 2018. The Company has also appointed Heytesbury Corporate LLP as company secretary with effect from 4 September 2018, and to provide accounting and financial management.

 

Non-Executive Director Derek Crowhurst, who had been over-seeing many of these tasks, has resigned as company secretary and stepped-off the Board with effect from 4 September 2018. The Company would like to thank Derek for his hard work in helping launch the Company, successfully acquiring the project in Cyprus and re-admitting the Company on to the Exchange. We wish Derek the very best for the future.

 

Competent Person Statement

 

The information in this announcement that relates to Exploration Results, Mineral Resources or Ore Reserves is based on information compiled by Dr Michael Green, who is a Member of the Australian Institute of Geoscientists.

 

Dr Green has sufficient experience, relevant to the style of mineralisation, type of deposits under consideration, and to the activity which he is undertaking, to qualify as a Competent Person as defined in the 2012 Edition of the 'Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves'. Dr Green has reviewed this announcement, and consents to the inclusion in the announcement of the matters based on his information in the form and context in which it appears. Dr Green is a shareholder of Chesterfield Resources.

 

Market Abuse Regulation (MAR) Disclosure

 

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

**ENDS**

 

For further information please visit www.chesterfieldresourcesplc.com or contact:

 

Chesterfield Resources plc:

Martin French, Executive Chairman         Tel: +44(0)7901 552277

 

Shard Capital (Broker):

Damon Heath                                               Tel: +44(0)20 7186 9952

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

UPDFKQDBQBKDNCK

Close

×

RNS Number : 6348Z

Xeros Technology Group plc

04 September 2018

 

RNS Reach

 

4th September 2018

 

Xeros Technology Group plc

 

Xeros to supply UAE with near-waterless commercial washing machines

 

Xeros Technology Group plc (AIM:XSG, 'the Group', 'Xeros'), the UK-headquartered technology business and innovator of a near-waterless laundry system, announces the supply of 32 near-waterless washing machines to Encom Trading LLC, a wholly owned subsidiary of Electro RAK, a leading UAE-based infrastructure services company and the appointed partner in the UAE to Hydrofinity, Xeros' cleaning technologies brand.

 

Electro RAK intends to install machines in premium hotels in the UAE. The first shipment will be made to Dubai during September.

 

The Xeros solution marks an unprecedented step forward for the commercial laundry industry, replacing water with its reusable XOrbTM technology to deliver up to an 80% reduction in water use and material reductions in both energy and detergent, whilst delivering a superior cleaning result and extended linen life.

 

The UAE faces critical water management challenges, given the inherent scarcity of groundwater and growing pressure on desalination and waste water infrastructures. In 2018, the country's Environment Agency warned that useable groundwater is expected to be fully depleted within 55 years at current rates of use.

 

Despite these conditions, the UAE has one of the highest per capita water consumption rates in the world. The cost burden of future-proofing the country's water infrastructure has led to growing tariffs for businesses and residents.

 

This agreement follows the recent shipment of 16 near-waterless washing machines to the Cape Province region of South Africa.

 

Mike Ferrand, Managing Director, Hydrofinity, said:

 

"Against the regional backdrop of water stress and high water prices, our near-waterless technology offers material sustainability benefits to customers in Dubai and across the UAE.

 

"We are ideally placed to help commercial customers significantly reduce water consumption and make material utilities cost savings, thereby delivering a positive economic and environmental impact."

-Ends-

 

Enquiries:

 

Xeros Technology Group plc Mark Nichols, Chief Executive Officer Paul Denney, Chief Financial Officer	Tel: 0114 321 6328
Jefferies International Limited (Nominated Adviser and Joint Broker) Simon Hardy / Will Soutar	Tel: 020 7029 8000
Berenberg (Joint Broker) Chris Bowman / Ben Wright / Laure Fine	Tel: 020 3207 7800
Instinctif Partners Adrian Duffield / James Gray	Tel: 020 7457 2020

 

About Xeros – 'Xeros uses less water to do more'

 

Xeros Technology Group plc is a platform technology company that is reinventing water intensive industrial and commercial processes. Xeros is currently working to radically improve economics and sustainability of manufacturing processes used in garment and fabrics and in their subsequent life cycle of cleaning.

 

Xeros uses its patented reusable and recyclable XOrb technologies to significantly reduce the amount of water used in a number of major applications with the remaining water becoming far more efficient and effective in either affixing or removing molecules from substrates such as fabrics and garments. The result being significant improvements in economic, operational and sustainability outcomes that are unattainable with traditional processes.

 

Xeros is organised in three divisions; Textile Technologies addressing garment finishing and dyeing markets, Tanning Technologies addressing the Leather industry and Cleaning technologies comprising domestic laundry, commercial laundry (recently branded "Hydrofinity") and the cleaning of high performance workwear (branded "Marken").

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAUOONRWOAKRAR

Close

×

RNS Number : 4730Z

EU Supply PLC

03 September 2018

 

RNS Reach

3 September 2018

EU Supply plc

("EU Supply", the "Company" or the "Group")

 

Contract Win in Europe

 

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce a new contract with a European Union funded aid organisation. The contract is for delivery of CTMTM as SaaS and related services and is expected to generate revenues of £110k over three years including integrations.

 

 

FURTHER ENQUIRIES

EU Supply PLC Tel: 020 7127 4545 Thomas Beergrehn, CEO   Fredrik Wallmark, CFO       Stockdale Securities Tel: 020 7601 6100 Tom Griffiths, Ed Thomas

 

A copy of this announcement is available at www.eu-supply.com.

 

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for e-sourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 8,000 European public sector bodies in 9 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013. In August and September 2015, the Company raised a total of £2.061m (before expenses) through a placing of new shares and the issue of first and second tranches of Convertible Loan Notes to institutional and other investors. On 25 May 2018, the Company announced that it had raised a further £600k (before expenses) through a placing and subscription of new shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAEFLFXVVFEBBB

Close

×

RNS Number : 3290Z

EU Supply PLC

31 August 2018

 

RNS Reach

31 August 2018

EU Supply plc

("EU Supply", the "Company" or the "Group")

 

Contract Wins in Denmark

 

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce two contract wins in Denmark. The clients are Damgaard Rådgivende Ingeniører, an advisory firm, and Fiskeristyrelsen, a government entity regulating the fishery. Both contracts are for delivery of CTMTM as SaaS and related services and the contracts are expected to generate revuenues of, in aggregate, up to approximately £100k over 4 years including integrations.

 

FURTHER ENQUIRIES

EU Supply PLC Tel: 020 7127 4545 Thomas Beergrehn, CEO   Fredrik Wallmark, CFO       Stockdale Securities Tel: 020 7601 6100 Tom Griffiths, Ed Thomas

 

A copy of this announcement is available at www.eu-supply.com.

 

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for e-sourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 8,000 European public sector bodies in 9 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013. In August and September 2015, the Company raised a total of £2.061m (before expenses) through a placing of new shares and the issue of first and second tranches of Convertible Loan Notes to institutional and other investors. On 25 May 2018, the Company announced that it had raised a further £600k (before expenses) through a placing and subscription of new shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAFMGFRNGNGRZM

Close

×

RNS Number : 3700Z

Midatech Pharma PLC

31 August 2018

 

—

31 August 2018

Midatech Pharma PLC

("Midatech" or the "Company")

 

Midatech Announces Interim Results from Proof of Concept Exploratory Study for its

MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology

 

–     Interim data for key oncology drug candidate MTD201 establishes favourable clinical profile compared to reference product Novartis' Sandostatin® LAR® ("SLAR")

–     Drug-release properties of MTD201 distinct from SLAR

–     Provides positive clinical 'proof of concept' for Midatech's Q-Sphera™ microsphere technology platform

Midatech Pharma PLC (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products for rare diseases in oncology and immunotherapy, today announces interim data from the 'first-in-human' study of MTD201 Q-Octreotide, a sustained-release treatment for carcinoid cancer and acromegaly.

 

The double-blind exploratory study compared tolerability, pharmacokinetics and growth hormone profiles after 30 mg intramuscular injections of MTD201 or Novartis' Sandostatin® LAR® in 24 healthy subjects. The primary objectives of this exploratory trial were to compare the sustained release profile of MTD201 to that of SLAR and to inform the design of a follow-on pivotal registration study.

 

Results from the study indicate that MTD201 produces a safe and effective sustained-release profile of octreotide, supporting a once-monthly treatment interval, as is indicated for SLAR. Therapeutic octreotide concentrations were achieved, and growth hormone levels were suppressed in this trial by an average of 25%, comparable with SLAR. The release profile of MTD201 was consistent in all subjects and showed no measurable burst release or dose-dumping. This reflects the precision and tuning available with the Q-Sphera microsphere platform. 

 

MTD201 treatment was well-tolerated and the number of adverse events was low, similar to SLAR. Injection site reactions were generally mild and short-lived. Pain at the injection site was reported in 8% (MTD201) and 25% (SLAR) of subjects, and injection site tenderness in 8% (MTD201) and 83% (SLAR) of subjects. 

 

SLAR injections were administered using the pre-packed, larger 19G needle, while MTD201 was given via a smaller 21G needle. This is a key advantage of MTD201 and the Midatech Q-Sphera™ technology compared to SLAR, in addition to other important potential benefits including a simpler and quicker reconstitution process, fewer reconstitution errors and wastage, and fewer needle blockages.

 

Based on these interim results, Midatech believes that MTD201 has been shown to be safe with advantageous sustained-release properties that support the continued development of a long-acting octreotide product alternative to SLAR. The favourable and improved 'no-burst' and lower variability in the profile of MTD201 suggests a distinct and improved product, rather than an equivalent product, to SLAR. In preparation for a follow-on regulatory trial, Midatech will seek additional regulatory opinion on pursuing approval for MTD201 as an equivalent product or a differentiated improved product.  The Company will make further announcements regarding the next steps for MTD201 in due course.

 

The results from this first-in-human study also provide a successful clinical 'proof of concept' for Midatech's Q-Sphera microsphere technology as a platform for other sustained release drug candidates, either developed internally or with partners.

 

Commenting on the results, Dr Craig Cook, Chief Executive Office of Midatech Pharma, said: "This study has generated several positive outcomes for Midatech.  First, for the MTD201 programme, whilst one objective of the study was to determine whether MTD201 was bioequivalent to Sandostatin LAR with a potentially shorter route to market, this data suggests that we have a better product with an improved clinical profile.  Combined with the other advantages around smaller needle size, simpler and more reliable reconstitution and injection, this could lead to a more valuable product either to develop internally or license to pharmaceutical partners.  Second, this study is a major validation and inflection point for Midatech's Q-Sphera™ technology establishing it as an exciting new sustained-release delivery platform, to administer pharmaceuticals safely, conveniently and effectively, without a burst phenomenon, and over a prolonged period.  After five years of development, we are delighted to have achieved positive first-in-human data.  We look forward to unlocking the full potential of our MTD201 programme as well as the Q-Sphera platform, both for Midatech and for our partners looking to capture a share of the multibillion dollar sustained-release treatment opportunities." 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR).

 

– Ends –

 

For more information, please contact:

 

Midatech Pharma PLC

Dr Craig Cook, CEO

+44 (0)1235 888 300

www.midatechpharma.com

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)

Corporate finance: Freddy Crossley / Emma Earl

Corporate broking: James Stearns

+44 (0)20 7886 2500

 

Consilium Strategic Communications (Financial PR)

Mary-Jane Elliott / Nicholas Brown / Angela Gray

+44 (0)20 3709 5700

[email protected]

 

Westwicke Partners (US Investor Relations)

Chris Brinzey

+1 339 970 2843

[email protected]

 

 

Notes for Editors

 

About Q-Sphera™ Microsphere Technology

Q-Sphera™ is a patented PLGA polymer microsphere technology that enables sustained drug delivery from tissue depots over periods of a few weeks to more than 6 months.   Q-Sphera™ technology is unique in utilizing piezo-electronics technology to individually print microspheres, enabling precise control of particle size, predictable pharmacokinetics with low variability in blood drug concentrations.

 

Potential advantages over conventional SR dosage forms include:

·      Improved patient experience (reduced needle size; reduced pain on injection)

·      Predictable and less variable blood drug levels

·      More efficient administration (fewer doses lost to reconstitution difficulties and needle blockages)

·      Improved manufacturing efficiency (avoids losses to control particle size and improves CoGs)

 

About MTD201 (Q-Octreotide)

MTD201 is an intramuscular Q-Sphera™ polymer microsphere formulation of octreotide that releases drug over an extended period to enable a monthly injection regimen.  Octreotide is a somatostatin analogue used clinically to manage conditions associated with excessive growth hormone secretion, and hormonal tumours.  MTD201 is being developed for the treatment of acromegaly and management of neuroendocrine cancer.

 

About Midatech Pharma PLC

Midatech is an international specialty pharmaceutical company focused on developing and commercialising products in oncology and immunotherapy for rare diseases via both in-house and partnered programs.  Our development pipeline of improved chemo- and immune-therapeutic drug candidates utilises Midatech's three platform drug delivery technologies, Midacore™, Q-Sphera™ and Nano-Inclusion technologies:  

 

–    Midacore™ is a leading gold nanoparticle technology that we are exploiting for targeted delivery of: i) existing chemotherapeutic agents to cancer cells, and ii) antigenic peptides to the immune system for immune-oncology applications.

–    Q-Sphera™ platform: our piezo-electric polymer microsphere technology for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months.

–    Nano-Inclusion platform: a nanosaccharide technology, used to dissolve drugs at the nanoscale for direct brain delivery of aqueous formulations to treat brain tumours

 

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" within the meaning of legislation in the United Kingdom and/or United States. Such forward-looking statements include, but are not limited to, statements regarding the ability of Midatech to successfully test, manufacture, produce or commercialize products for conditions using the nanoparticle, sustained release drug delivery or Nano Inclusion platforms, and the ability for products in development to achieve positive clinical results, and the ability to meet or achieve timelines associated with pre-clinical studies, clinical trials or regulatory submissions. Any forward-looking statements are based on currently available competitive, financial and economic data together with management's views and assumptions regarding future events and business performance as of the time the statements are made and are subject to risks and uncertainties. We wish to caution you that there are some known and unknown factors that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.

 

Reference should be made to those documents that Midatech shall file from time to time or announcements that may be made by Midatech in accordance with the London Stock Exchange AIM Rules for Companies ("AIM Rules"), the Disclosure and Transparency Rules ("DTRs") and the rules and regulations promulgated by the US Securities and Exchange Commission, which contains and identifies other important factors that could cause actual results to differ materially from those contained in any projections or forward-looking statements. These forward-looking statements speak only as of the date of this announcement. All subsequent written and oral forward-looking statements by or concerning Midatech are expressly qualified in their entirety by the cautionary statements above. Except as may be required under the AIM Rules or the DTRs or by relevant law in the United Kingdom or the United States, Midatech does not undertake any obligation to publicly update or revise any forward-looking statements because of new information, future events or otherwise arising.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

UPDGUGDIXXXBGIB

Close

×

RNS Number : 9473Y

Avanti Communications Group Plc

28 August 2018

 

28 August 2018

 

Avanti Communications Group plc

("Avanti" or "the Group")

Avanti Communications plc announces Master Distribution Agreement with COMSAT INC.

Avanti Communications plc, (AVN:L)  the UK Satellite operator has announced a seven year, Master Distribution Agreement (MDA) with Washington-based COMSAT INC, leading suppliers of Satellite communications services to the US DoD and US Government.

With this agreement, Avanti gains immediate access to US global governmental and military activity  that may otherwise take multiple years to gain approval to serve.

COMSAT will benefit from the Avanti advanced satellite fleet and particularly from the Hylas 4 satellite, a High‐Throughput Satellite (HTS), focused on the Middle East and Africa. Hylas‐4, with four uniquely steerable HTS beams and a further 64 Fixed beams, will enter service in September, 2018.

 

 

For further information, please contact:

Avanti Communications	Chris McLaughlin (Chief of Corporate and External Affairs) Tel: +44 20 7749 1600
Montfort	Nick Miles,  James Olley Tel: +44 203 770 7909
Cenkos Securities (Nomad)	Max Hartley Tel: +44 207 397 8900
Redleaf Communications	Ralph Anderson +44 (0)20 3757 6883

 

About Avanti

Avanti connects people wherever they are – in their homes, businesses, in government and on mobiles. Through the HYLAS satellite fleet and partners in 118 countries, the network provides ubiquitous internet service to a quarter of the world's population.

Avanti delivers the level of quality and flexibility that the most demanding telecoms customers in the world seek. Avanti is the first mover in high throughput satellite data communications in EMEA. It has rights to orbital slots and KA-band spectrum in perpetuity that covers an end market of over 1.7bn people. The Group has invested $1.2bn in a network that incorporates satellites, ground stations, datacentres and a fibre ring.

Avanti has a unique Cloud-based customer interface that is protected by patented technology. Avanti Communications is listed in London on AIM (AVN: LSE). www.avantiplc.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTLIFEETVITFIT

Close

×

RNS Number : 3611Y

Veltyco Group PLC

21 August 2018

 

21 August 2018

 

Veltyco Group plc

("Veltyco", the "Company" or the "Group")

 

Betsson Services contract renewed, update on receivables

and launch of own regulated brand

 

Betsson contract renewed

 

Veltyco Group plc (AIM:VLTY), the online marketing and operating company for the gaming industry, is pleased to announce that its wholly owned subsidiary, Sheltyco Enterprises Ltd, has agreed with Betsson Services Ltd ("Betsson"), the sports book operator, to renew Veltyco's marketing agreement until May 2021.  Pursuant to the new agreement, Veltyco will continue to exclusively market Betsson's Betsafe brand in Germany on broadly similar terms as the previous agreement.

 

Betsson is part of the Betsson AB group, the Swedish quoted investor and manager of companies in the online gaming industry, with a market capitalisation of approximately €885 million.  Betsafe is one of the leading global online gaming brands, with over 450,000 customers from over 100 countries.  There is an increasing global recognition of the Betsafe brand, as demonstrated by Betsson's sponsorship of London-based, Saracens Rugby Club and boxer Tony Bellew.

 

Veltyco has been working with Betsson since March 2012 as its exclusive marketing partner for the German speaking market, receiving a share of all revenues generated from the Betsafe brand in German speaking countries, in recognition of its marketing activities.  Historically, Veltyco has increased the visibility and recognition of the Betsafe brand, through premium marketing partnerships with top German Bundesliga clubs and other high-profile sporting events.

 

The renewal of the marketing agreement with Betsson is further to the disclosure in Veltyco's 2017 Annual Report and Accounts, in which the Company confirmed that it had, subject to documentation, reached agreement with Betsson to further extend its existing marketing agreement.  If Veltyco's relationship with Betsson is expanded beyond the current geographic arrangement, this will be subject to further agreement and further announcements will be made as appropriate.

 

Commenting on the contract renewal, Gilles Ohana, Chairman of Veltyco, said: "Since inception, Betsafe has formed a core part of the Group's operations.  The partnership jointly leverages both companies' respective strengths including Betsson's and Betsafe's clear operational excellence and Veltyco's core expertise in Germany.  Betsson's confidence in Veltyco in extending its marketing agreement in Germany through to 2021, further strengthens our relationship and we very much look forward to continuing the expansion of the Betsafe brand in Germany to the benefit of all parties."

 

Update on receivable position

 

As at 17 August 2018, the Group's total receivable balance amounted to, in aggregate, €8.9 million, excluding accrued income in respect of the Group's online financial trading activities for June and July 2018.  The current cash position of the Company has increased to €1.3 million, with a further €0.35 million expected to be received before the end of August 2018 from Celestial Trading Limited ("Celestial"), which now operates the online financial trading brands, as well as the second monthly instalment of €0.3 million due from Altair Entertainment NV ("Altair"), resulting in an expected cash balance at the end of August 2018 of approximately €1.8 million.

 

As indicated in the Group's final results announcement for the year ended 31 December 2017, the majority of the Group's receivable balance relates to its marketing activities for online financial trading.  As at 17 August 2018, receivables in respect of these marketing activities amounted to €8.5 million, excluding accrued income for June 2018 of approximately €0.7 million and for July 2018 which is still to be finalised in the ordinary course of business.  €5.4 million of this balance is due from Celestial, of which €1.5 million relates to activities in 2017 and €3.9 million relates to activities in 2018.  €1.8 million of the balance due in respect of 2018 activities is overdue and the remaining €2.1 million is within current payment terms.  The remainder of the balance due in relation to marketing activities for online financial trading, being €3.1 million, is due from Altair in respect of the Group's activities in 2017 and, as announced on 26 July 2018, Veltyco has reached agreement with Altair to reduce this balance by a minimum of €0.3 million per month, with the first payment having been received as planned during July 2018.

 

Whilst this receivable balance is expected to increase in the short term due to the invoicing of currently accrued income, good progress is being made with Celestial to reduce the amounts due to the Company and the Directors believe that the Group's receivable balance will be reduced going forward, as regular payments are received from Celestial.  In addition, the Directors are seeking to reduce the payment terms in respect of online financial trading, which, once implemented, will further improve the Group's receivable balance during the second half of 2018.

 

The Group also continues to expand its corporate banking relationships, which is expected to assist the Group in reducing this receivable balance and this process is expected to continue through the second half of 2018.

 

The Company will make further announcements in relation to the above as appropriate.

 

Launch of own regulated brand

 

In May 2018 the Company acquired a database of users active in the online trading sector and the Group is making good progress in respect of launching its own regulated brand in the online financial trading sector, which is expected in Q4 2018.

 

Given the Group's experience in the online financial trading sector, the Directors believe that the launch of the Group's own regulated brand is the logical next step in the Group's development, as this will result in the Group receiving a larger proportion of the revenues from its activities in the sector.  In addition, it will also result in monies being received directly by the Group from such activities, as opposed to receiving payments from third parties in respect of the Group's marketing activities, which will help mitigate the build-up of receivables in the future.  The Company will keep shareholders updated on progress in this regard. 

 

Commenting on these Company matters, Gilles Ohana, Chairman of Veltyco, said: "We believe that meaningful progress has been achieved in addressing and normalising the receivables balance, and we are now looking forward to the next phase of the Company's development with the launch of its own regulated brand in the online trading sector."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information please contact:

 

Veltyco Group Plc                                                                             +44 (0)1624 605 764

Gilles Ohana, Chairman

Melissa Blau, Chief Executive Officer

Marcel Noordeloos, Chief Financial Officer

 

Strand Hanson Limited (Nominated Adviser)                            +44 (0)20 7409 3494

James Harris / Richard Tulloch / James Dance

 

Whitman Howard Ltd (Broker)                                                      +44 (0)20 7659 1234

Nick Lovering / Christopher Furness

 

IFC Advisory (Financial PR & IR)                                                    +44 (0)20 3934 6630

Graham Herring / Miles Nolan / Zach Cohen

 

About Veltyco

Veltyco is a group of companies focused on generating marketing leads and entering into marketing contracts for the activities of various partners in the gaming industry as well as operating its own brands.  Veltyco focuses on complementary activities under one umbrella, leveraging its historical cash generative activities of marketing online casinos and sports betting.

 

Website: www.veltyco.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCZMGZRZGLGRZZ

Close

×

RNS Number : 3578Y

Pennant International Group PLC

21 August 2018

 

                                                                                                                                                           

 

FOR IMMEDIATE RELEASE                                                                                                21 August 2018       

                                                   

PENNANT INTERNATIONAL GROUP PLC

 

 

Contract Award from New Customer

&

Contract Extension

 

 

Pennant International Group plc ("Pennant" or the "Group"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist engineers in the defence and regulated civilian sectors, is pleased to announce that it has been awarded a contract by a new customer and that it has agreed a beneficial extension to an existing contract with another.

 

New Customer

 

Following a successful tender in open competition, Pennant has been awarded a long-term contract by an undisclosed new government client in the Asia-Pacific region. 

 

The contract is for the supply of virtual training software to help air force maintenance engineers practice procedures, functionality and diagnostics in a virtual environment. Pennant will be supplying its Virtual Aircraft Training System ("VATS") (with customer-specific modifications).

 

The VATS product has been undergoing a significant upgrade to its user interface and 3D models in readiness for this sale and for other potential customers. The software will be supplied to the new customer later this year on a perpetual licence. Pennant will be providing ongoing support and maintenance for the software under a ten-year arrangement with the customer.

 

Contract Extension

 

Pennant's Software Services division (home to the OmegaPS software product) has received an order from an existing customer (in the maritime sector) to continue the provision of consultancy and technical documentation services until June 2021.

 

OmegaPS is a logistical support and analysis tool used to reduce the operating costs of major capital equipment in the defence, aerospace and transportation markets.

 

David Clements, Group's Commercial & Risk Director, commented:

 

"We are very pleased to add these two contracts to the order book. The VATS contract was awarded following a very competitive tender process and we look forward to supporting this new customer's training needs over the coming years, whilst the OmegaPS contract extension is testament to this product's market-leading capabilities. Both contracts will contribute to the Group's forward visibility of earnings over a number of years".

 

 

 

Enquiries:

 

Pennant International Group plc	www.pennantplc.co.uk
Philip Walker, CEO David Clements, Commercial & Risk Director	+44 (0) 1452 714 914
Walbrook PR (Financial PR)	[email protected]
Paul Vann / Tom Cooper	+44 (0)20 7933 8780 Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRADBGDIUBDBGIG

Close

×

RNS Number : 8069X

DeepMatter Group PLC

15 August 2018

 

15 August 2018

DeepMatter Group plc

("DeepMatter", the "Company" or the "Group")

Further Pioneer Agreements Signed and Notice of Interim Results

 

DeepMatter (AIM: DMTR), the AIM listed company focusing on digitizing chemistry, announces that it has now entered into agreements with a total of five organisations for its DigitalGlassware™ Pioneer Programme, which represents the minimum that it planned to initiate during 2018. 

 

In addition to the two agreements signed with leading international life science reagent and chemicals manufacturers which were announced by the Company during April 2018, the Company now has signed agreements with three further pioneers, comprising a world-renowned US-headquartered research centre and two universities – one in the UK and one in North America.  Entering into agreements with this range of target users reflects the Company's previously described plan to select a range companies and institutions to trial its technology, allowing observation of technology performance in different operating environments and locations worldwide.  The Company anticipates entering into further pioneer agreements.

 

The Company's DigitalGlassware™ platform, comprising a powerful and easy-to-use software interface with a unique, low footprint sensor array, collects, stores and processes data generated from chemical experiments and allows access to reproducible chemistry via internet protocols.

 

Under the agreements, each of the Pioneer partners are entitled to multiple instances on the DigitalGlassware™ platform, including hardware and software.  Each of the Pioneers is providing manpower and other resources, performing experiments and tests it wishes to perform, in addition to experiments and tests suggested by DeepMatter.  The experiments and tests are contributing towards context rich data content, capable of being interrogated with Artificial Intelligence and Machine Learning algorithms, as well as exploring DigitalGlassware's full operating potential.

 

These observations will contribute towards future technology optimisation, prior to wider dissemination to target users.  The Pioneer companies will also assess the performance of the DigitalGlassware™ platform, specifically to understand how it can help improve the outcomes of chemical processes, including precision and reproducibility, with an eye to how the technology can help in discovering/enabling new synthetic routes and chemical entities.

 

To date across the Pioneer Programme, which formally started in May 2018, the DigitalGlassware™ platform has been used to collect data from over 5,500 hours of chemistry across over 240 individual experimental runs. 77GiB of data has been collected and structured, comprising nearly 0.9 billion data points from sensors and inputs.  These data will be subjected to deep learning methodologies in the quest for unique chemical insights.

 

Notice of unaudited interim results

The Group expects to announce its unaudited interim results for the six months ended 30 June 2018 on 6 September 2018. 

 

 

For further information:

DeepMatter Group plc	www.deepmatter.io
Mark Warne, Chief Executive Officer	T:  0141 465 6871
Stockdale Securities Limited	T: 020 7601 6100
Tom Griffiths/Edward Thomas

 

 

 

 

DeepMatter Group Plc is a public limited company registered in England and Wales with registered number 5845469 and VAT registered number 225 8481 94. DeepMatter Group plc's shares are admitted to trading on AIM, a market operated by the London Stock Exchange. The registered office is at The Walbrook Building, 25 Walbrook, London, EC4N 8AF. DeepMatter Limited is a private limited company registered in Scotland with registered number SC456741 and VAT registered number 193 1502 21. The registered office is at 38 Queen Street, Glasgow, G1 3DX. This message is intended solely for the addressee and may contain confidential information. If you have received this message in error, please send it back to us, and immediately and permanently delete it. For the avoidance of doubt, unless specifically confirmed in this email as approved final versions, any attached documents are in draft form and should not be referred to, relied upon or quoted for any purpose other than informing us whether any changes are required. Internet communications are not secure or error free and we do not accept any liability for the content of this e-mail. Although e-mails are routinely screened for viruses the sender does not accept responsibility for any damage caused.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

MSCGGUQPRUPRGQC

Close

×

RNS Number : 6748X

Netcall PLC

14 August 2018

 

14 August 2018

RNS Reach

 

NETCALL PLC

("Netcall", the "Company", or the "Group") 

MATS Contract Renewal

Netcall plc (AIM: NET), a leading provider of Low-code and customer engagement software, is pleased to announce that it has secured a minimum £1.6 million 3 year contract renewal with a leading UK bank (the "Customer") for its Low-code platform, MATS.

The Customer has been using MATS for over 11 years to support core business processes such as mortgage applications, customer notifications and a document management portal, enabling the streamlining of internal processes and improvement to customer services. 

MATS has a strong market position within financial services, with MATS applications supporting processing of approximately 30% of UK mortgage applications. Industry leading organisations understand that Low-code can transform customer experience, boost productivity and keep their operations agile. 

Henrik Bang, CEO of Netcall commented: "We are delighted this long-standing MATS customer has renewed its contract for a further three years, underlining the strategic importance of the Low-code platform and MATS' leading position in the rapidly growing Low-code market."

For further enquiries, please contact:

Netcall plc	Tel. +44 (0) 330 333 6100
Henrik Bang, CEO Michael Jackson, Chairman James Ormondroyd, Group Finance Director
finnCap Limited (Nominated Adviser and Broker)	Tel. +44 (0) 20 7220 0500
Stuart Andrews / James Thompson, Corporate Finance
Tim Redfern, Corporate Broking
Alma PR	Tel. +44 (0) 20 8004 4218
Caroline Forde / Josh Royston / Robyn Fisher

 

About Netcall plc

Netcall is a UK company quoted on the AIM market of the London Stock Exchange. Netcall helps organisations transform their customer engagement activities and enable digital transformation faster and more efficiently, thereby improving customer experiences and operational efficiencies. Netcall's software product portfolio comprises Liberty, a customer engagement platform, incorporating omnichannel contact centre and workforce optimisation, and a leading low-code platform MATS.

Netcall has over 700 customers in both the private and public sectors. These include two-thirds of the NHS Acute Health Trusts, major telecoms operators such as BT and Vodafone, and leading organisations including Interflora, Lloyds Banking Group, ITV and Nationwide Building Society.

For further information, please consult the Netcall website: www.netcall.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAFKNDBCBKDAFD

Close